7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Uremia D014511 33 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diarrhea D003967 32 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Neoplasms, Experimental D009374 10 associated lipids
Hypercalcemia D006934 13 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lung Neoplasms D008175 171 associated lipids
Wounds and Injuries D014947 20 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Body Weight D001835 333 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Wang D et al. Accelerated calvarial healing in mice lacking Toll-like receptor 4. 2012 PLoS ONE pmid:23071670
Shah AP et al. Effects of Minocycline on Urine Albumin, Interleukin-6, and Osteoprotegerin in Patients with Diabetic Nephropathy: A Randomized Controlled Pilot Trial. 2016 PLoS ONE pmid:27019421
Funck-Brentano T et al. Targeting bone alleviates osteoarthritis in osteopenic mice and modulates cartilage catabolism. 2012 PLoS ONE pmid:22432033
Zhang Y et al. Enhanced osteoclastic resorption and responsiveness to mechanical load in gap junction deficient bone. 2011 PLoS ONE pmid:21897843
Kuroda Y et al. Osteoprotegerin Regulates Pancreatic β-Cell Homeostasis upon Microbial Invasion. 2016 PLoS ONE pmid:26751951
Plasilova M et al. Discordant gene expression signatures and related phenotypic differences in lamin A- and A/C-related Hutchinson-Gilford progeria syndrome (HGPS). 2011 PLoS ONE pmid:21738662
Pan X et al. Association of TRAIL and Its Receptors with Large-Artery Atherosclerotic Stroke. 2015 PLoS ONE pmid:26334877
Yang DC et al. cAMP/PKA regulates osteogenesis, adipogenesis and ratio of RANKL/OPG mRNA expression in mesenchymal stem cells by suppressing leptin. 2008 PLoS ONE pmid:18253488
Zhang J et al. Feeding blueberry diets to young rats dose-dependently inhibits bone resorption through suppression of RANKL in stromal cells. 2013 PLoS ONE pmid:23936431
Di Bartolo BA et al. TRAIL-deficiency accelerates vascular calcification in atherosclerosis via modulation of RANKL. 2013 PLoS ONE pmid:24040204
Genre F et al. Osteoprotegerin CGA haplotype protection against cerebrovascular complications in anti-CCP negative patients with rheumatoid arthritis. 2014 PLoS ONE pmid:25184828
Åšliwicka E et al. Serum irisin and myostatin levels after 2 weeks of high-altitude climbing. 2017 PLoS ONE pmid:28732027
Bergdolt S et al. Osteoblast-specific overexpression of complement receptor C5aR1 impairs fracture healing. 2017 PLoS ONE pmid:28614388
Liu J et al. MicroRNA-32 promotes calcification in vascular smooth muscle cells: Implications as a novel marker for coronary artery calcification. 2017 PLoS ONE pmid:28319142
Shetelig C et al. Osteoprotegerin levels in ST-elevation myocardial infarction: Temporal profile and association with myocardial injury and left ventricular function. 2017 PLoS ONE pmid:28253327
Nolen BM et al. Prediagnostic serum biomarkers as early detection tools for pancreatic cancer in a large prospective cohort study. 2014 PLoS ONE pmid:24747429
Kamata R et al. EPA Prevents the Development of Abdominal Aortic Aneurysms through Gpr-120/Ffar-4. 2016 PLoS ONE pmid:27764222
Liu HJ et al. Substance P Promotes the Proliferation, but Inhibits Differentiation and Mineralization of Osteoblasts from Rats with Spinal Cord Injury via RANKL/OPG System. 2016 PLoS ONE pmid:27764190
O'Sullivan S et al. Tyrosine Kinase Inhibitors Regulate OPG through Inhibition of PDGFRβ. 2016 PLoS ONE pmid:27737004
Tawfeek H et al. Disruption of PTH receptor 1 in T cells protects against PTH-induced bone loss. 2010 PLoS ONE pmid:20808842
Djamiatun K et al. Severe dengue is associated with consumption of von Willebrand factor and its cleaving enzyme ADAMTS-13. 2012 PLoS Negl Trop Dis pmid:22563509
Ryser MD et al. Osteoprotegerin in bone metastases: mathematical solution to the puzzle. 2012 PLoS Comput. Biol. pmid:23093918
Beederman M et al. Osteoprotegerin deficiency results in disruption of posterofrontal suture closure in mice: implications in nonsyndromic craniosynostosis. 2015 Plast. Reconstr. Surg. pmid:26017615
Xu Y et al. Inhibition of bone metastasis from breast carcinoma by rosmarinic acid. 2010 Planta Med. pmid:20157877
Oliver JL et al. Differential expression and tumor necrosis factor-mediated regulation of TNFRSF11b/osteoprotegerin production by human melanomas. 2013 Pigment Cell Melanoma Res pmid:23490134
Jang S et al. Wogonin inhibits osteoclast formation induced by lipopolysaccharide. 2010 Phytother Res pmid:19998398
Tantikanlayaporn D et al. A diarylheptanoid phytoestrogen from Curcuma comosa, 1,7-diphenyl-4,6-heptadien-3-ol, accelerates human osteoblast proliferation and differentiation. 2013 Phytomedicine pmid:23557993
Wang Y et al. Puerarin concurrently stimulates osteoprotegerin and inhibits receptor activator of NF-κB ligand (RANKL) and interleukin-6 production in human osteoblastic MG-63 cells. Phytomedicine pmid:24854571
Bitto A et al. Genistein aglycone effect on bone loss is not enhanced by supplemental calcium and vitamin D3: a dose ranging experimental study. 2011 Phytomedicine pmid:21397481
Srivastava S et al. Assessment of the role of flavonoids for inducing osteoblast differentiation in isolated mouse bone marrow derived mesenchymal stem cells. 2013 Phytomedicine pmid:23570998
Hsieh TP et al. Icariin inhibits osteoclast differentiation and bone resorption by suppression of MAPKs/NF-κB regulated HIF-1α and PGE(2) synthesis. 2011 Phytomedicine pmid:20554188
Wang F et al. Icariin enhances the healing of rapid palatal expansion induced root resorption in rats. 2012 Phytomedicine pmid:22818561
Chen B et al. Canonical Wnt signaling is required for Panax notoginseng saponin-mediated attenuation of the RANKL/OPG ratio in bone marrow stromal cells during osteogenic differentiation. 2012 Phytomedicine pmid:22818895
Zajícková K et al. Is A163G polymorphism in the osteoprotegerin gene associated with heel velocity of sound in postmenopausal women? 2008 Physiol Res pmid:18271681
Xu M et al. Low-intensity pulsed laser irradiation affects RANKL and OPG mRNA expression in rat calvarial cells. 2009 Photomed Laser Surg pmid:18800943
Li N et al. Calycosin attenuates osteoporosis and regulates the expression of OPG/RANKL in ovariectomized rats MAPK signaling. 2016 Pharmazie pmid:29441931
Gradosova I et al. The role of atorvastatin in bone metabolism in male albino Wistar rats. 2011 Pharmazie pmid:21901984
Wang GF et al. Influence of baicalin on the expression of receptor activator of nuclear factor-kappaB ligand in cultured human periodontal ligament cells. 2006 Pharmacology pmid:16636611
Gradosova I et al. Protective effect of amlodipine on rat bone tissue after orchidectomy. 2012 Pharmacology pmid:22302040
Dawson S and Lawrie A From bones to blood pressure, developing novel biologic approaches targeting the osteoprotegein pathway for pulmonary vascular disease. 2017 Pharmacol. Ther. pmid:27373854
Treuheit MJ et al. Inverse relationship of protein concentration and aggregation. 2002 Pharm. Res. pmid:12033388
Pipes GD et al. Optimization and applications of CDAP labeling for the assignment of cysteines. 2005 Pharm. Res. pmid:16028006
Miyaji Y et al. Novel comb-shaped PEG modification enhances the osteoclastic inhibitory effect and bone delivery of osteoprotegerin after intravenous administration in ovariectomized rats. 2012 Pharm. Res. pmid:22729371
Nemec K and Schubert-Zsilavecz M [Future therapies for metabolic bone diseases. New concepts and targets]. 2001 Pharm Unserer Zeit pmid:11715689
Wang AY Vascular and other tissue calcification in peritoneal dialysis patients. 2009 Perit Dial Int pmid:19270239
Bartold PM et al. Mechanisms and control of pathologic bone loss in periodontitis. 2010 Periodontol. 2000 pmid:20403105
Nagasawa T et al. Roles of receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoprotegerin in periodontal health and disease. 2007 Periodontol. 2000 pmid:17214836
Petersson M et al. Oxytocin stimulates proliferation of human osteoblast-like cells. 2002 Peptides pmid:12126740
Honsawek S et al. Relationships between OPG, RANKL, bone metabolism, and bone mineral density in biliary atresia. 2009 Pediatr. Surg. Int. pmid:19184056
Bargman R et al. High- and low-dose OPG-Fc cause osteopetrosis-like changes in infant mice. 2012 Pediatr. Res. pmid:22926546

Table of Content